Cannabis CBD against Tremor? (Study of Tremor Treatment with Marijuana)

Many people with disabilities try to deal with the disease, for example, with medicines that are originally designed for different disabilities. High pressure powders are often examples. Medical cannabis is currently in the States (to de is already permitted for medical use) prescribed against 31 different types of diseases. Only now, however, did it begin to talk about its use in the case of tremors.

High CBD content as a medical choice for scientists

Doctor Fatta Nahab , a neurologist at the University of San Diego, is the head of a tremor study on cannabis. He tells how he enlightened him about the use of marijuana when he saw two patients with his own eyes who immediately stopped shaking for a moment after smoking a joint. He also watched people on the Internet who were able to end their tremors using CBD products purchased online.

When applying for permission, the university decided to use a 20: 1 treatment formula of CBD: THC. Large ratio CBD over minimal THC has been chosen in particular to minimize the psychoactive effects of cannabis. The University of Applied Drug also had to list data such as purity, durability, or toxicity. The researchers also had to discuss all the details of the study with the official California State Advisory Panel and get all the security clearance before starting the study.

The university plans to acquire at least 20 patients. The full-scale research should burst forth in early 2019. The required data gathered by either dou bracelets that measure and write inAll changes in tremor before and after taking the cannabis therapeutic formula. Tilray will provide the study with some financial support, but it will not interfere with the study and any negative or positive results in any other way.

First cannabis imported from Canada

The newly acquired San Diego University permit also marks the first ever moment when medical cannabis from Canada will be imported legally and for clinical research. The problem and a considerable brake on research is mainly the US legislation that still considers cannabis a federally banned substance. This basically means that if scientists wanted to obtain cannabis for research from one of the many legmedical marijuana dispensers to patients, they would commit federal crime, even if the state of cannabis was absolutely legal.

Instead of simply buying quality material from a local dispensary, researchers need to ask the American National Drug Agency (DEA) to provide cannabis samples. It should also be noted that DEA has only one source of cannabis - marijuana grown at the University of Mississippi. Scientists have long á Eta complain about the difficulty of obtaining permission to take this cannabis. In addition, cannabis samples from this university are notoriously poor, and it has been found several times that Mississippi marijuana has been infected with mold. You can imagine how cannabis of such quality will lead you during your research.

CBD Capsules for better drug dosing

The University of California is also planning to acquire special capsules to accurately measure the dose of CBD. In the case of inhalation of cannabis hemp, scientists can never be quite sure whether it was a all subjects administered the same amount of active ingredient. The r ecisions for use the capsules had been led to the assumption that this way to study logs in ETSI numbers of elderly patients Most seniors would be discouraged from participating in cannabis inhalation.

However, there is another problem here - the US Drug Administration does not provide capsules. Researchers had to spend an incredible two years trying to overcome all the bureaucratic pitfalls. Eventually, however, their efforts returned and the import of quality cannabis from Canada (where marijuana is already under the federal law legal) is already in preparation.

The representative of the activist legalization company, NORML, Paul Armentano , says this is a typical illustration of how poorly American researchers are supplying good cannabis and how this problem fundamentally slows down the entire process of scientific progress. However, the US government recently approved a proposal to permit and launch at least two other cannabis research institutes .

"The fact that American scientists are willing to fight for years with a horde of legislative barriers to begin research on cannabis treatment points out and great interest in science medical, s m arihuan y . ”Explains Armentano .

An important milestone in cannabis research

The legal import of medical cannabis to the USA from abroad has been done several times in the past. An example is the import of the first cannabis drug authorized by the US State Food and Drug Administration, Epidiolex . Epidiolex is a product of the British pharmaceutical company GW class Pharmaceuticals focused on the treatment of severe cases of epilepsy.

Good news also comes from the above-mentioned Tilray , which claims to be on track to work with many research teams. The company firmly believes in its own ability to provide a world-class cannabinoid cannabis that meets all national quality requirements. Their efforts are reflected in several such permits today.

"Permission to provide our research product is a huge milestone for us and for the entire scientific community and industry," explains Catherine Jacobson, head of clinical research at Tilray . "Today we were scientists restrictions on research applications of hemp only in the form of dried flowers. Now js me, however, the federal government finally convinced that we are able to produce first-class drugs with a net content of cannabinoids in various forms that meet all of their requirements for standard quality. "